Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Long-Term Projected Growth Rate for the Vaccine Delivery Devices Market, and What Are the Key Drivers?

There has been a significant expansion in the market size of vaccine delivery devices in recent years. A growth from $6.39 billion in 2024 to a projected $7.06 billion in 2025 with a compound annual growth rate (CAGR) of 10.5% is anticipated. Factors contributing to this growth in the historic period include extensive polio vaccination drives, expanded immunization programs (EPI), the use of disposable syringes, campaigns to eradicate smallpox, along with initiatives such as the global alliance for vaccines and immunization (GAVI) and the vaccine alliance.

The market for vaccine delivery devices is predicted to experience swift expansion in the coming years, rising to a valuation of $10.41 billion by 2029 with a compound annual growth rate (CAGR) of 10.2%. This expected growth during the forecast period can be linked to several factors such as the increased focus on immunization programs, an expanded pipeline for vaccine development, growth in pediatric and geriatric demographics, emphasis on cold chain management, and heightened emphasis on preventative healthcare practices. Key trends projected during this period include ongoing innovation in the technology of vaccine delivery devices, increased attention on needle-free solutions, developments in personalized medicine, novel self-administered vaccines, and industry partnerships.

What Drivers Are Shaping the Growth of the Vaccine Delivery Devices Market?

The anticipated rise in infectious diseases is anticipated to boost the vaccine delivery devices market’s growth. These diseases, caused by harmful microorganisms like bacteria, viruses, fungi, or parasites, can be transmitted from one person to another, or via animals, vectors, or contaminated objects. The spread of such diseases is attributed to factors such as increased global travel, rapid urbanization, shifting climate patterns, and population expansion. Vaccination delivery devices are integral in preventing the spread of these illnesses by effectively providing vaccines, building immunity, and minimizing transmission. For example, the World Health Organization (WHO), a Switzerland-based UN agency focused on global health, reported approximately 10.6 million cases of tuberculosis (TB) worldwide in 2022. The statistics included 5.8 million men, 3.5 million women, and 1.3 million children affected. Hence, the wide occurrence of infectious diseases is bolstering the expansion of the vaccine delivery devices market.

Request Your Free Vaccine Delivery Devices Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=15952&type=smp

Which Companies Are Leading the Charge in Expanding the Vaccine Delivery Devices Market?

Major companies operating in the vaccine delivery devices market are:

• Pfizer Inc.

• Johnson & Johnson

• Merck & Co. Inc.

• Sanofi S.A.

• Novartis International AG

What New Trends Are Reshaping the Vaccine Delivery Devices Market and Its Opportunities?

Leading corporations in the vaccine delivery devices market are focusing on product innovation to boost the effectiveness and safety of vaccine administration – a notable example being the development of prefillable syringes. These are drug administration devices that are specially engineered to store and deliver a set dosage of a medication, usually a vaccine in liquid form. In September 2022, an illustrative case involved Becton, Dickinson and Company (BD), a medical technology firm hailing from the US, which unveiled the BD Effivax Glass Prefillable Syringe. This state-of-the-art vaccine delivery device is designed to address the progressively changing needs of vaccine production. With an aim to augment efficiency and dependability in vaccine administration, this syringe employs advanced technology and stringent specifications. It ensures improved fill or finish and container dependability, helping to mitigate the possibilities of production line interruptions while boosting the manufacturing capacity.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/vaccine-delivery-devices-global-market-report

Which Market Segments Are Driving Strategic Growth and Trends in the Vaccine Delivery Devices Market?

The vaccine delivery devices market covered in this report is segmented –

1) By Type Of Device: Needle Free Injection Systems, Oral Delivery Systems, Nasal Delivery Systems, Jet Injectors, Microneedle Patches And Microinjectors

2) By Route Of Administration: Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination, Other Vaccinations

3) By End Users: Hospitals, Clinics, Other End Users

Subsegments:

1) By Needle Free Injection Systems: Spring-Based Injectors, Gas-Driven Injectors, Hybrid Injectors

2) By Oral Delivery Systems: Oral Tablets And Capsules, Oral Sprays, Oral Solutions

3) By Nasal Delivery Systems: Nasal Sprays, Nasal Drops, Nasal Powder Systems

4) By Jet Injectors: Pneumatic Jet Injectors, Electromechanical Jet Injectors

5) By Microneedle Patches And Microinjectors: Dissolvable Microneedles, Solid Microneedles, Microinjector Devices

What Are the Top Regions Fueling Growth in the Vaccine Delivery Devices Market?

North America was the largest region in the vaccine delivery devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vaccine delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Defines the Scope of the Vaccine Delivery Devices Market?

Vaccine delivery devices are tools or systems designed to administer vaccines safely and effectively to individuals. These devices are designed to ensure accurate dosage, proper delivery, and minimal discomfort for the patient. Vaccine delivery devices play a crucial role in public health efforts by facilitating the distribution and administration of vaccines to prevent infectious diseases.

Browse Through More Similar Reports By The Business Research Company:

Pertussis Vaccine Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report

H1N1 Vaccine Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/h1n1-vaccine-global-market-report

Inactivated Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/inactivated-vaccines-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: